after his retirement in 2011, mendelsohn remained on the faculty as co-director of the new sheikh khalifa bin zayed al nahyan institute for personalized cancer therapy. he was a senior fellow in health and technology at the baker institute. mendelsohn was only the third full-time president of md anderson.